A group of novel 4-substituted phenylacetic acids were prepared and coupled with several 7-amino-J-3-cephems to afford a family of parenterally active cephalosporins.
A group of novel 4-substituted phenylacetic acids were prepared and coupled with several 7-amino-J-3-cephems to afford a family of parenterally active cephalosporins.
A compound designated 131 had the broadest spectrum of activity and the highest potency of the group against both Gram-positive and Gram-negative bacteria. The activity of 131 included high potency against penicillinase-producing staphylococci and activity against anaerobes, including Bacteroides fi•agilis.
In a previous publication'' we have shown how a variety of novel substituted-aryl amino acids 1 were prepared by nucleophilic displacement of a selectively chloromethylated a-amino-4-hydroxyphenylacetic acid (1, R'=C1).
Moreover once these amino acids were coupled with 7-aminocephems, a family of orally active cephalosporins 2 was obtained. In this paper we present the synthesis of a series of 4-substituted phenylacetic acids 3 and the group of parenterally active cephalosporins 4 derived from them (Scheme 1).
Chemistry A new process for the preparation of 4-chloromethylphenylacetic acid'' (3a, RI =C1 in 3) has been developed. Treatment of 5 with sodium acetate in acetic acid gave a mixture of 6, unreacted 5 and a small amount of diester 7, from which 6 was isolated and treated with sodium cyanide to give 8. The cyanoester 8 when hydrolyzed with concentrated hydrochloric acid gave the desired 3a in a 54 % overall yield (Scheme 2).
The acid 3a was converted to the acylchloride 9 which was then coupled by standard procedures') with 3-substituted-7-aminocephems 12". Subsequent displacement of the chloride group with a variety * Author to whom correspondence should be directed . Table 2 ).
An alternative synthetic approach involved the prior convertion of 3a to other p-substitutedmethylphenylacetic acids 3 (Table 1) , followed by direct coupling of the corresponding acyl halides 10 with the desired cephems 11.
In Table 1 are listed some of the novel 4-substituted-methylphenyl acetic acids 3 which have been prepared. In Table 2 are listed the cephalosporanic acid derivatives obtained on Table 1 Antibiotic Spectrum Minimal inhibitory concentrations (MICs) were determined using serial twofold dilutions of compounds in a growth medium followed by its inoculation. To obtain inocula for MIC determinations, all cultures except anaerobes were grown 18 -24 hours at 37°C in Trypticase soy broth (BBL). The Trypticase soy broth tubes containing the antibiotics were inoculated so that the final concentration of cells represented a culture dilution of 1 x 10-1 for Streptococcus pneumoniae and Streptococcus pyogenes and I x 10-5 for all other cultures. Anaerobes were grown for 48 hours at 37°C in thioglycolate broth (BBL) and then diluted I x 10-1 in MUELLER-HINTON broth (BBL). Using the multiple inoculator of STEERS et al.,5) the diluted cultures (0.003 ml) were applied to the surface of MUELLER-HINTON agar containing 1 % Supplement C (Difco) and the antibiotics. Tubes were incubated at 37°C in air for 18 hours. Agar plates were incubated at 37°C for at least 24 hours in the atmosphere created by using the Gas Pak (BBL) hydrogen-I-carbon dioxide generating system in a Gas Pak Anaerobic Jar. After incubation, the lowest concentration of antibiotic causing inhibition of visible growth was considered to be the MIC.
Treatment of Experimental Infections in Mice
Albino CD-I male mice weighing 20(±1) g were infected by intraperitoneal injection of a bacterial suspension containing a sufficient number of organisms to produce uniformly lethal infections. The suspensions were in brain heart infusion broth and were 0.1 to 1.0 ml in volume, depending upon the organism. Suspensions of S. aureus M238 and Escherichia coli Es59 contained 2.5% mucin. Groups of ten mice each were treated subcutaneously with appropriate concentrations of antibiotic at 1 and 4 hours after infection. The number of mice in each group surviving the challenge for 4 days was recorded and the ED,, (the dose in mg/kg required to protect 50 ° of the infected mice) determined by the method of REED and MUENCHO>.
Results and Discussion

Activity In Vitro
The in vitro spectra of activity and potencies of the more biologically interesting compounds against common pathogens are shown in Table 3 . Of all of the compounds tested having the 7-aminocephalosporanic acid (7-ACA) nucleus, compound 13k possessed the broadest spectrum was generally the most potent, and compared favorably to cephalothin, which also has the 7-ACA nucleus. The congener of 13k, 131, which has a methyltetrazolylthio group in place of the acetoxy of 13k, had the broadest spectrum and was the most potent of all of the compounds prepared. It was more potent than cephalothin or cefazolin (which also bears a met hylthioheterocycle at C-3) against the Gram-positive bacteria and was equipotent to or more potent than the two reference compounds against all of the Gram-negative bacteria. Additional testing of these compounds found that 13k and 131 were more potent than their respective reference compounds, cephalothin and cefazolin, against penicillinase-producing staphylococci (Table 4) NT, not tested. OCT. 1981 Activity In Vivo
All of the compounds were effective to varying degrees against certain Gram-positive and Gramnegative bacterial mouse infections when administered subcutaneously; none was active orally. The most potent compound was 131, being more potent than cephalothin and equipotent to or more potent than cefazolin, depending upon the mouse infection (Table 6 ).
Summary
In summary, 131 was the most biologically interesting compound of the series described. It possessed a medium broad spectrum of activity, was highly potent against penicillinase-producing staphylococci, and it was active against anaerobes, including Bacteroides fragilis.
Experimental
The NMR spectra of all cephalosporin derivatives 12, 13 were consistent with their proposed structures.
Only the coupling of 9 with one 7-amino cephem 11 is presented as well as one general procedure for the nucleophilic displacement of the chloride. All other compounds listed in Table 2 were prepared by analogous methods. a-Acetoxy-a'-chloro-p-xylene (6) A mixture of a,a'-dichloro p-xylene (5, 175 g, I mole) and 300 ml of glacial acetic acid was heated to 90'C with continuous stirring.
At this temperature sodium acetate anhydrous (102.6 g, 1.25 mole)
was added in 2-3 portions. The mixture was further heated at reflux temperature for 90 minutes, it was then cooled and filtered.
The solid contained unreacted 5, and sodium chloride and was further worked up to recover 5. The filtrate was flash concentrated and filtered to give a solid consisting of a second batch of unreacted 5 and sodium acetate.
The filtrate was then distilled. Three fractions were collected b.p. 158°C, 160-170°C and 188°C at 20 rnmHg, consisting respectively of 5, 6 and 7. The second fraction weighed 75 g (85.2% yield) and was used without further purification. NT, not tested.
THE JOURNAL OF ANTIBIOTICS the addition the mixture was further heated at 7080°C for 3 hours. The mixture was cooled and was extracted with five portions of 150 ml chloroform. The combined organic phase was washed twice with 150 nil of water, dried, treated with charcoal and evaporated to dryness to give 56.2 g (73.7% yield) of crude 8 which was used in the next step without further purification.
4-Chloromethylphenylacetic Acid (3a)
A mixture of 8 (54.6 g, 0.29 mole) and concentrated hydrochloric acid (550 ml) was heated to 70-80 "C for 2 hours. Upon cooling to ]0°C the crude acid 3a which precipitated weighed 55.5 g, it was recrystallyzed from hot toluene (2,200 ml) to give a total of 44.5 g of 3a (86 % yield), m.p. 156 -157°C (Ref.2), 152 -153°C) in two crops.
NMR (Me,CO-de) 1 3.62 (s, 2), 4.68 (s, 2), 7.37 (s, 4).
4-Chloromethylphenylacetyl Chloride (9)
A solution of 3a (10 g, 0.057 mole) in 60 ml of thionyl chloride was stirred at room temperature for 24 hours. The excess reagent was removed under high vacuum to give 10.5 g (95 % yield) of Crude crystalline 9 which was used without further purification.
NMR (CDC13) o 4.17 (s, 2), 4.58 (s, 2), 7.48 (m, 4).
4-Cyanomethylphenylacetic Acid (3b)
A solution of 3a (1 g, 5 mmole) and sodium cyanide (2 g, 40 mmole) in 30 ml of methanol was refluxed for 4 hours. The solvent was flash evaporated and the residue was dissolved in a mixture of dichloromethane and water which was acidified to pH 3 with 10 % hydrochloric acid. The organic phase was separated, dried and concentrated to give a residue which was chromatographed on silica gel using To a solution of sodium bicarbonate (1.5 g, 0.018 mole) and 11 (Y = 1-methyltetrazol-5-ylthio) (3.28 g, 0.01 mole), in 30 ml of water and 20 ml of acetone was added 9 (2.03 g, 0.01 mole) in 10 nil of acetone. The mixture was stirred for 45 minutes at room temperature and was then treated with charcoal and filtered. The filtrate was flash concentrated at 25°C, to remove the acetone. Thiourea (0.76 g, 0.01 mole) was added to the aqueous residue. After a short period of vigorous stirring a heavy precipitate formed. Stirring was continued for 30 minutes and the product isolated by filtration was washed repeatedly with water and dried, giving 4. 
